Cardinal Capital Management Inc (North Carolina)’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-98,791
Closed -$17.1M 124
2015
Q1
$17.1M Buy
98,791
+49,652
+101% +$7.29M 7.21% 1
2014
Q4
$5.65M Hold
49,139
2.58% 4
2014
Q3
$7.68M Hold
49,139
3.65% 1
2014
Q2
$6.06M Hold
49,139
3.01% 4
2014
Q1
$5.09M Buy
49,139
+913
+2% +$93.5K 2.62% 4
2013
Q4
$4.34M Hold
48,226
2.22% 8
2013
Q3
$3.23M Hold
48,226
1.83% 18
2013
Q2
$3.19M Buy
+48,226
New +$2.76M 1.89% 15

Other funds holding SLXP

Cardinal Capital Management Inc (North Carolina)'s SLXP Position: Q2 2015 in Review

Cardinal Capital Management Inc (North Carolina) sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 98,791 shares — an estimated $17.1M sold.

Cardinal Capital Management Inc (North Carolina) first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $17.1M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Cardinal Capital Management Inc (North Carolina) reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Cardinal Capital Management Inc (North Carolina) sold 98,791 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $17.1M.
  • Cardinal Capital Management Inc (North Carolina) first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Cardinal Capital Management Inc (North Carolina)'s SALIX PHARMACEUTICALS LTD DEL position peaked at $17.1M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Cardinal Capital Management Inc (North Carolina)'s 13F filing for Q2 2015, filed 3 Aug 2015.